| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/22/1984 | EP0101039A2 Monoclonal antibody, method of producing the same and use thereof |
| 02/22/1984 | EP0100904A2 Improved protocol for the treatment of graft versus host disease |
| 02/21/1984 | US4432969 Inhalent allergen and saponin for desenitization |
| 02/21/1984 | US4432751 Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
| 02/21/1984 | CA1162480A1 Veterinary vaccines |
| 02/16/1984 | WO1984000540A1 Polypeptide |
| 02/15/1984 | EP0100752A2 Process for the preparation of a rabies vaccine, holder and means for its administration and process for oral immunisation |
| 02/15/1984 | EP0100734A1 Process for the separation or purification of a sleep promoting factor from a biological source by immunological reaction of the antigen-antibody kind |
| 02/15/1984 | EP0100710A2 Vaccine for the immunization of animals and men against Toxoplasma Gondii |
| 02/15/1984 | EP0100561A1 Yeast hybrid vectors and their use for the production of polypeptides |
| 02/15/1984 | EP0100522A2 Protein PP17, process for concentrating and obtaining it and its use |
| 02/15/1984 | EP0100521A2 Process for the production of a herpes antigen, appropriate means therefor and a process for its production, and the use of this antigen |
| 02/14/1984 | US4431633 Influenza vaccine |
| 02/14/1984 | CA1162147A1 Feline vaccines |
| 02/08/1984 | EP0100104A1 Muramyldipeptide derivatives |
| 02/07/1984 | US4430260 Penicillin-polyvinyl alcohol conjugate and process of preparation |
| 02/07/1984 | CA1161837A1 Preparation of allergens |
| 02/02/1984 | WO1984000420A1 New reagent for the diagnostic of parasitosis and allergia, process for the preparation of this new reagent and process for the diagnostic of parasitosis and allergia by means of said reagent |
| 02/02/1984 | WO1984000382A1 Improved protocol for the treatment of graft versus host disease |
| 02/02/1984 | WO1984000301A1 Propagation of hemorrhagic enteritis virus in a turkey cell line |
| 02/02/1984 | WO1984000300A1 Haemophilus influenzae b polysaccharide exotoxoid conjugate vaccine |
| 02/02/1984 | WO1984000294A1 A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
| 02/01/1984 | EP0099812A1 Reagent for the diagnosis of parasitosis and allergies, method for the preparation of this reagent and method of diagnosing parasitosis and allergies using this reagent |
| 01/31/1984 | US4429046 Large scale cultivation of Bordetella pertussis cells for vaccine production |
| 01/31/1984 | US4429045 Rabies virus adapted for growth in swine testicle cell culture |
| 01/31/1984 | US4428965 Tolerizing and desensitizing compounds, compositions and methods of treatment against dermatological conditions caused by allergens from plants and trees of the Anacardiaceae and Ginkgoaceae families |
| 01/31/1984 | US4428941 Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby |
| 01/31/1984 | US4428932 Pharmaceutical compositions |
| 01/31/1984 | US4428931 Bacterial toxoids and gram-negative immune globulin therefrom |
| 01/25/1984 | EP0099133A2 Anti-cancer drugs comprising platinum complexes |
| 01/25/1984 | EP0098867A1 Blue tongue virus vaccine and method of producing same |
| 01/24/1984 | US4427782 Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis |
| 01/24/1984 | US4427777 Enzymatic conversion of red cells for transfusion |
| 01/24/1984 | US4427659 Apyrogenic immunostimulants |
| 01/24/1984 | CA1160942A1 Process and reagent for the determination of the activity of creatine kinase-mb |
| 01/19/1984 | WO1984000110A1 Polypeptide active immunosuppressant fraction |
| 01/19/1984 | WO1984000109A1 Vaccines against pathogenic bacteria with capsular polysaccharides and process for the preparation thereof |
| 01/18/1984 | EP0098581A2 Haemophilus influenzae B polysaccharide exotoxoid conjugate vaccine |
| 01/18/1984 | EP0098557A2 Preparation for the diagnosis of chlamydial infections and for the production of chlamydial group-specific antibodies |
| 01/18/1984 | EP0098520A1 L-alanyl-D-isoglutaminyl-adamantyl amide, process for its preparation and pharmaceutical compositions containing this compound |
| 01/18/1984 | EP0098431A2 Pharmaceutical composition comprising immune globulin and fibronectin |
| 01/11/1984 | EP0098252A2 New and novel glycosides, glycoconjugates and processes for their preparation |
| 01/11/1984 | EP0098162A2 Monoclonal antibodies specific to carcinoembryonic antigen |
| 01/10/1984 | US4425330 Bovine mastitis vaccine and method for detecting efficacy thereof |
| 01/10/1984 | CA1160218A1 Valproate conjugation using dicarbonyls |
| 01/04/1984 | EP0097518A2 Monoclonal antibody |
| 01/04/1984 | EP0097440A1 Method and kit for removing and assaying complement system fragments |
| 01/04/1984 | EP0097407A1 Vaccines against diseases causing bacteria with capsular polysaccharides and process of preparing them |
| 01/03/1984 | CA1159820A1 Immunologic adjuvants |
| 12/28/1983 | EP0097003A2 Vaccine prepared employing platinum compounds |
| 12/27/1983 | US4423038 Immunostimulants; potentiation of antibiotics |
| 12/27/1983 | US4423035 Adding gentamicin sulfate |
| 12/27/1983 | CA1159366A1 Vaccine against newcastle fowl disease and method for preparing same |
| 12/22/1983 | WO1983004371A1 Inactivation of a lipid virus |
| 12/22/1983 | WO1983004370A1 Method for the preparation of a vaccine against pathogenic parasites |
| 12/21/1983 | EP0096463A1 Immunoglobulin half-molecules and process for producing hybrid antibodies |
| 12/21/1983 | EP0096422A2 Process for the preparation of a vaccine against pathogenic parasites |
| 12/21/1983 | EP0096293A1 N-acetylglucosamine derivatives, process for their preparation and their use to combat malaria |
| 12/21/1983 | EP0096292A1 Beta-D-galactose derivatives, process for their production and their use |
| 12/20/1983 | US4421653 Treatment with maleic anhydride copolymer crosslinked with diamine and hydrolyzed |
| 12/20/1983 | CA1158978A1 Process for obtaining lipid envelope virus subunits, notably antigens for use as vaccines, the products obtained and their applications |
| 12/13/1983 | US4420398 Filteration method for cell produced antiviral substances |
| 12/08/1983 | WO1983004313A1 Human-human hybridomas for neoplasms |
| 12/07/1983 | EP0095873A2 Region-specific determinants for vitamin K dependent bone protein |
| 12/07/1983 | EP0095502A1 Human monoclonal antibodies or lymphokines in separation of cells or diagnosis of mammary cancer |
| 12/06/1983 | US4419444 Agglutination |
| 12/06/1983 | US4419348 Anthracycline glycoside compositions, their use and preparation |
| 11/30/1983 | EP0095452A2 Preparation of DNA sequences and DNA recombinant molecules coding for the cholera toxine units A and B, the products obtained and compositions containing the unit(s) obtained |
| 11/30/1983 | EP0095426A1 Synthetic polypeptides containing at least one sequence of the choleric B1 sub-unit toxin, and medicines containing them |
| 11/30/1983 | EP0095346A2 Hybrid cell lines producing monoclonal antibodies directed against treponema |
| 11/30/1983 | EP0094997A1 Bovine mastitis vaccine, process for preparing it, and method for detecting efficacy thereof |
| 11/24/1983 | WO1983004054A1 A method for determination of deoxythymidine kinase (dtk) isoenzyme activity and use thereof for the diagnosis of diseases |
| 11/24/1983 | WO1983004052A1 New vectors for the expression of the antigenic protein of rabies and application thereof to the preparation of vaccines |
| 11/24/1983 | WO1983003972A1 Production of enterovirus neutralizing antibodies from vp1 |
| 11/23/1983 | EP0094923A2 A method of determining dTk isoenzyme activity and the use thereof |
| 11/23/1983 | EP0094887A2 Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines |
| 11/23/1983 | EP0094611A2 A method for the heat treatment of plasma of plasma fractions and compositions obtained thereby |
| 11/23/1983 | EP0094575A2 Compositions for treatment of disease states involving immunological factors |
| 11/22/1983 | US4416986 Hepatitis b surface antigen grown on hollow fiber cells-vaccine |
| 11/22/1983 | CA1157465A1 Synthetic antigenically-active polypeptide and a process for its preparation |
| 11/22/1983 | CA1157373A1 Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s) |
| 11/16/1983 | EP0094233A1 Immune modulator peptides |
| 11/16/1983 | EP0093851A2 Fatty acid carriers for synthetic vaccines |
| 11/15/1983 | US4415733 Ganglioside derivatives, their preparation and their application |
| 11/15/1983 | US4415700 Hydrophilic latex particles and use thereof |
| 11/15/1983 | US4415553 Compositions, processes for their preparation and method for treatment of neoplasms |
| 11/15/1983 | US4415552 Composition for establishing immunological tolerance |
| 11/15/1983 | US4415493 Immune modulator peptides |
| 11/09/1983 | EP0093652A1 Synthetic toxin ST, process for its preparation and its use as a vaccination agent |
| 11/09/1983 | EP0093438A2 Non-A, Non-B hepatitis antigen |
| 11/09/1983 | EP0093436A2 Process for preparing permanent animal and human cell lines, and their use |
| 11/09/1983 | EP0093375A1 Culture medium and process for the multiplication of viruses in a suspension culture |
| 11/08/1983 | US4414204 With a muramyl-peptide |
| 11/08/1983 | US4414201 Immunopotentiator containing abrin |
| 11/08/1983 | US4414148 Anti-cancer drugs for the treatment of melanomas and method for preparing thereof |
| 11/08/1983 | CA1156647A1 Preparation of native oncornavirus envelope subunits and vaccines therefrom |
| 11/08/1983 | CA1156553A1 Process for the production of vaccine |
| 11/08/1983 | CA1156519A1 Process for the preparation of stable suspensions or powders for the manufacture of stable microcapsules of varying porosity, and products so obtained |
| 11/02/1983 | EP0092918A2 Continuous release formulations |
| 11/01/1983 | US4412990 Composition having enhanced opsonic activity |